ReviewClinical pharmacology and therapeutics2026

Biomarker Utilization for Regulatory Decision Making: A Landscape Analysis of Neurological Drug Products Approved by FDA (2008-2024).

Dahee Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.